• Home
  • About Steve Woodruff
  • Contact
  • About Impactiviti

Impactiviti blog

Pharma needs? Ask Steve.

Feeds:
Posts
Comments
« Today’s Top Pharma News 071609
Pharma and Social Media: Progress! »

An e-Vent on Pharma Social Media

July 21, 2009 by Steve Woodruff

I’m at a conference on Physician Relationship Management (MDRx). As usual, we’re talking e-marketing, social media, and fear. If  you know pharma, you know that anything new is embraced with enthusiastic expressions of…terror.

Often, the starting points for these discussions are the following:

    1. How are we going to do this and keep clean on the regulatory front?
    2. What’s the quickly-demonstrable ROI?
    3. Risk. Risk. Risk.
    4. Who else is doing it?

So, of course, these starting points doom the participants – who often are in short-term marketing rotations – to think about “safety in tactics,” rather than strategic opportunities.

Careful – you might shoot your eye out.

There are structural reasons in this industry for this mentality. However, if we’re going to make any progress, I’d like to suggest that anyone thinking about Networked Communications strategies in pharma START with only two perspectives:

    1. What are the needs of our audience(s)?
    2. How can we add value?

That’s it. Begin the initial discussions there and leave all the other stuff for the last 5 minutes, or you’ll never approach it with an opportunity mindset. Now I know that all these other concerns have to be addressed, but that’s like choosing your outfit only after putting on handcuffs and chains.

That’s my e-Vent at this event. Your thoughts?

———-

Subscribe to the Impactiviti blog via e-mail

Subscribe to the Impactiviti blog via RSS

Connect with Steve Woodruff

About these ads

Share this:

  • Twitter
  • StumbleUpon
  • Facebook
  • Email

Like this:

Like Loading...

Posted in Communications, Conference, Meetings, Networking, Outsourcing, Pharma, Pharmaceutical, Social Media, Web | 1 Comment

One Response

  1. on July 22, 2009 at 6:54 am Sally

    Steve,

    Well that weird, because I had a similar experience yesterday but with a client rather than at a conference. You could have been summarising my conversations with those 4 questions!

    It’s more like a death spiral sometimes, as Seth Godin alluded to and that’s what caught my eye this morning:

    http://www.pharmastrategyblog.com/2009/07/death-spiral-in-pharma.html

    The two questions you raise are exactly how I have been trying to get them to focus, but the climate of fear is pretty overwhelming in many places right now and they are scared of making mistakes. Sad really.



Comments are closed.

  • Welcome!


    Steve Woodruff
    sw
    President, Impactiviti
    Pharmaceutical Connection Agent
  • Connect with Steve Woodruff


    SteveWoodruff.com
  • Testimonials


    “Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics

    Read More Testimonials
  • Free ebook! Getting Started with Social Networking

  • Subscribe!

    Subscribe in a reader
  • Subscribe via e-mail

    Subscribe to Impactiviti blog by Email
  • Subscribe to our e-newsletter

    View our Archive
    Email Marketing by Constant Contact®

  • Bookmark



  • Recent Posts

    • SPBT 2013: Looking Up
    • Client-Vendor Success White Paper
    • How Not to Be Outstanding as a Vendor Company
    • Just Say NO to (some) New Business
    • Is Pharma Sales Dead?
    • We Do Everything…Just Like Everybody Else!
    • Create Your Vendor Map
    • Create Your Vendor Funnel
    • Friday Notes 3_8_13
    • Fresh Job Postings
  • Recent Comments

    Marketers: What Woul… on About Steve Woodruff
    Glen Drummond on Is Pharma Sales Dead?
    Andrew Nemiccolo (@n… on Is Pharma Sales Dead?
    DenVan on We Do Everything…Just Li…
    Steve Woodruff (@swo… on We Do Everything…Just Li…
  • Archives

    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • December 2011
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • February 2010
    • January 2010
    • December 2009
    • November 2009
    • October 2009
    • September 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • December 2008
    • November 2008
    • October 2008
    • September 2008
    • August 2008
    • July 2008
    • June 2008
    • May 2008
    • April 2008
    • March 2008
    • February 2008
    • January 2008
    • December 2007
    • November 2007
    • October 2007
    • September 2007
    • August 2007
    • July 2007
    • June 2007
    • May 2007
    • April 2007
    • March 2007
    • February 2007
    • January 2007
    • December 2006
    • November 2006
    • October 2006
    • September 2006
    • August 2006
    • July 2006
  • Categories

    • Abbott
    • Advertising
    • After Hours
    • Allergan
    • Amgen
    • Amylin
    • Assessment
    • AstraZeneca
    • Avandia
    • Bayer
    • Biotech
    • Blogging
    • Blogs
    • BMS
    • Boehringer Ingelheim
    • book review
    • Branding
    • Bristol Myers
    • Business
    • Career planning
    • Celgene
    • Cephalon
    • Communications
    • Conference
    • Consulting
    • Covidien
    • Daiichi Sankyo
    • Depression
    • Diabetes
    • DTC
    • eLearning
    • Eli Lilly
    • Entrepreneur
    • ePatients
    • epharma
    • Ethics
    • facebook
    • FDA
    • Forest Labs
    • Friday Collection
    • Fun
    • Genentech
    • Genzyme
    • Glaxosmithkline
    • GSK
    • Healthcare
    • Impactiviti
    • Inspiration
    • Interview
    • iPad
    • J&J
    • Job
    • Job Board
    • John Mack
    • Johnson and Johnson
    • Lilly
    • Marketing
    • Medical Devices
    • Medicine
    • Meetings
    • Merck
    • Mobile
    • Music
    • Musings
    • Networking
    • News
    • No Bad Training
    • Novartis
    • Novo Nordisk
    • Obesity
    • Oncology
    • Outsourcing
    • Parenting
    • Paul Potts
    • Personal
    • Peter Rost
    • Pfizer
    • Pharma
    • Pharma News
    • Pharmaceutical
    • Project Management
    • Purdue
    • Recommendations
    • Red Cross
    • Reviews
    • Right-sourcing
    • Roche
    • Sales
    • Sales training
    • Sanofi-Aventis
    • Scandal
    • Schering
    • Social Media
    • SPBT
    • Spoof
    • Starting a business
    • Statins
    • Takeda
    • Technology
    • The Pharma Side
    • Top News
    • Training
    • Training Needs
    • Twitter
    • Uncategorized
    • Vendor Management
    • Vendor Selection
    • Video
    • Web
    • Webinar
    • Wyeth
    • Wyth
  • Add to Technorati Favorites
    Alltop, all the top stories
  • Pages

    • About Impactiviti
    • About Steve Woodruff
    • Contact

Blog at WordPress.com.

Theme: MistyLook by WPThemes.


Follow

Get every new post delivered to your Inbox.

Powered by WordPress.com
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: